A Russian company is hoping to revolutionise the treatment of HIV patients around the world with the help of a grant from the Skolkovo Foundation. Currently, Russia's one million HIV patients take a daily cocktail of tablets. Viriom is working on...
Infectex , a resident of the Skolkovo Foundation’s biomed cluster, has completed clinical trials in Russia of its new drug for treating TB, the company announced on Friday, World Tuberculosis Day. The drug – SQ109 – has demonstrated high...
Russian pharmaceutical companies looking to enter the U.K. market – and vice versa – will meet with their British counterparts at a two-day conference at the Skolkovo innovation centre next week to forge new partnerships in developing innovative...
A group of students from Eton College, the U.K.’s most famous school, visited the Skolkovo innovation centre on Wednesday, where they were inspired by a selection of Russian startups including an exo-skeleton, a microsatellite and a surgery simulator...